Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Gregg Moskowitz Remains Bullish on GitLab with Revised Price Target of 75

Elaine Mendonca by Elaine Mendonca
March 5, 2024
in Breaking News
0
Software-solutions-technology
0
SHARES
15
VIEWS
Share on FacebookShare on Twitter

Mizuho analyst Gregg Moskowitz remains bullish on GitLab (NASDAQ: GTLB) with a Buy rating and a revised price target of $75, down from $87, in light of the current AI craze impacting the market. Despite recent dips in the stock price, Moskowitz maintains confidence in GitLab’s future prospects.

Back in January 8, 2024, Moskowitz upgraded GitLab from Neutral to Buy with a price target of $73. Following the earnings call on March 4, 2024, analysts are optimistic about GitLab’s performance, expecting quarterly earnings of 8 cents per share and revenue of $158.21 million for the latest quarter. Analysts like Truist Securities’ Barry Jonas and DA Davidson’s Gil Luria have also made adjustments to their ratings and price targets for GitLab in recent months.

Overall, despite the fluctuations in GitLab’s stock value, analysts such as Gregg Moskowitz from Mizuho continue to believe in the company’s potential by maintaining a Buy rating and adapting price targets to align with market conditions.

GTLB Stock Price Analysis: Significant Movements on March 5, 2024

On March 5, 2024, GTLB stock experienced some significant price movements. According to data from CNN Money, GTLB was trading near the top of its 52-week range and above its 200-day simple moving average, indicating positive price momentum for the stock.

The price of GTLB shares increased by $1.16 since the market last closed, representing a 1.58% rise from the previous closing price of $74.47. This increase in price may have been driven by positive market sentiment or company-specific news that investors found favorable.

However, despite the initial price increase, GTLB stock dropped by $17.12 in pre-market trading. This sudden drop in price could be attributed to a variety of factors, such as profit-taking by investors who had benefited from the earlier price rise, or negative news impacting the broader market or the company itself.

GTLB Stock Analysis: Revenue Increases, Net Income Decreases – What Investors Need to Know

On March 5, 2024, GTLB stock had a mixed performance based on the financial data provided by CNN Money. The company reported a total revenue of $579.91 million for the past year, which represents a 36.66% increase compared to the previous year. Additionally, the total revenue for the last quarter was $163.78 million, showing a 9.43% increase compared to the previous quarter.

However, despite the increase in revenue, GTLB reported a net income of -$424.17 million for the past year, which is a significant decrease of 146.17% compared to the previous year. On a positive note, the net income for the last quarter improved to -$36.47 million, representing an 87.21% increase compared to the previous quarter.

Earnings per share (EPS) for GTLB stock was reported at -$2.75 for the past year, showing a decrease of 136.78% compared to the previous year. The EPS for the last quarter remained steady at -$0.23, with no change compared to the previous quarter.

Overall, while GTLB stock showed improvement in total revenue and net income for the last quarter, the company still faces challenges in turning a profit and increasing EPS. Investors may want to closely monitor the company’s financial performance and future growth strategies to make informed decisions about investing in GTLB stock.

Tags: GTLB
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Aptevo Therapeutics Surprises Analysts with BetterThanExpected Quarterly Losses

Financing and finances

Analyzing Short Interest Trends in Fisker Potential for a Short Squeeze

NeoGames SA Partners with Georgia Lottery Corporation to Introduce Premium eInstants

Recommended

Rocket Companies Stock

Rocket Companies Stock Surges on Fed Policy Speculation

7 months ago
Biopharmaceutical Markets and money (1)

Groundbreaking Preclinical Data on TN301 A Potential Breakthrough in Treating HFpEF

2 years ago
Airbnb Stock

Airbnb Faces Dual Challenges as Insiders Sell and Fee Structure Shifts

7 months ago
MSCI World ETF Stock

MSCI World ETF Reaches New Heights Amid Tech Sector Surge

6 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Regulatory Proposal Sparks Sell-Off in Coinbase Shares

UnitedHealth Faces Multifaceted Regulatory Scrutiny Ahead of Earnings

Intel’s Capital Reshuffle and Leadership Transition Revealed in Annual Filing

35,000 Guards for 359 Million Doors: The Cyber Deficit Wall Street Can No Longer Ignore

Palo Alto Networks Finalizes Debt Terms Following CyberArk Acquisition

Kuya Silver Shares Show Signs of Technical Recovery

Trending

Oracle Stock
AI & Quantum Computing

Oracle’s Backlog Soars on Cloud and AI Contract Momentum

by Jackson Burston
March 25, 2026
0

While much of the market's attention remains fixed on the developers of large AI models, Oracle has...

Alphabet Stock

Regulatory Scrutiny Looms Over Alphabet’s Aggressive AI Expansion

March 25, 2026
Ocugen Stock

Ocugen Shares Tumble Despite Positive Clinical Trial Results

March 25, 2026
Coinbase Stock

Regulatory Proposal Sparks Sell-Off in Coinbase Shares

March 25, 2026
Unitedhealth Stock

UnitedHealth Faces Multifaceted Regulatory Scrutiny Ahead of Earnings

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Oracle’s Backlog Soars on Cloud and AI Contract Momentum
  • Regulatory Scrutiny Looms Over Alphabet’s Aggressive AI Expansion
  • Ocugen Shares Tumble Despite Positive Clinical Trial Results

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com